Streetbeat News

Stock Prices

SJM

J.M. Smucker Company (NYSE:SJM) reported its fourth-quarter FY24 earnings, showing a 1.3% decline in sales to $2.21 billion, missing estimates. However, adjusted EPS of $2.66 beat expectations. Gross profit increased by 15%, and the company provided a positive outlook for FY25. SJM shares are up 2.87% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

June 06, 2024 | 12:56 pm

LLY

FDA staff reviewers have reported a higher number of deaths in participants treated with Donanemab compared to those given a placebo. The deaths were not fully explained by ARIA or cerebral hemorrhage.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:56 pm

SNGX

Trading for SNGX was halted and then resumed at 8:55:00 AM ET. The halt was due to pending news, and trading resumed after the news was released.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:55 pm

LYFT

Lyft shares are trading higher after the company provided 2027 financial targets ahead of its Investor Day.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:49 pm

BNRG

Brenmiller Energy shares are trading higher following the announcement of an exclusive distribution agreement with Rock Energy Storage to sell and distribute its bGen TES systems.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:47 pm

ABBV

AbbVie announced positive topline results from its Phase 2 PICCOLO trial evaluating mirvetuximab soravtansine for high folate receptor-alpha expressing platinum-sensitive ovarian cancer. The trial met its primary endpoint with an ORR of 51.9% and a median DOR of 8.25 months. No new safety concerns were identified.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:47 pm

LYFT

UBER

Lyft expects a 15% CAGR in gross bookings from 2024 to 2027, reaffirms its 2024 financial outlook, projects a 4% adjusted EBITDA margin of gross bookings by 2027, and anticipates over 90% free cash flow conversion of adjusted EBITDA annually from 2025 to 2027.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:47 pm

NVAX

Novavax Inc. (NASDAQ: NVAX) shares surged 21.60% in pre-market trading after announcing plans to deliver a COVID-19 vaccine by September, following a recommendation from a U.S. regulatory advisory group.

Portfolio Pulse from Benzinga Neuro

June 06, 2024 | 12:46 pm

HALO

Halozyme Therapeutics shares are trading higher after the company raised its FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 12:44 pm

CVS

CVS Health Corporation (NYSE: CVS) shares closed slightly higher on Wednesday. JPMorgan analyst Lisa Gill maintained an Overweight rating but lowered the price target from $101 to $86. Baird analyst Michael Ha initiated coverage with a Neutral rating and a price target of $61. CVS Health reported Q1 sales of $88.4 billion, missing the consensus of $89.21 billion, and lowered its 2024 adjusted EPS guidance. The company has a dividend yield of 4.38%, translating to a quarterly dividend of 66.5 cents per share. To earn $500 monthly from CVS dividends, an investor would need approximately 2,256 shares, worth around $136,939.

Portfolio Pulse from Avi Kapoor

June 06, 2024 | 12:42 pm